Open Access

Poster Session 2 - Atrial fibrillation pathophysiology and mechanisms

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 1 September 2019

Session

10 presentations in this session

Autoantiboides to muscarinic m2 cholinoceptors in patients with paroxysmal atrial fibrillation

Speaker: Doctor E. Mironova (Moscow, RU)
Thumbnail

Quantitative global proteomics and lysine acetylome analysis of changes in left atrial appendage tissue from valvular heart disease patients with atrial fibrillation

Speaker: Doctor T. Tu (Changsha, CN)
Thumbnail

Pioglitazone inhibits diabetes-induced atrial mitochondrial oxidative stress and improves mitochondrial biogenesis, dynamics and function through the PGC-1 signaling pathway

Speaker: Professor G. Tse (Tianjin, CN)
Thumbnail

CD8+CD28null T lymphocytes are associated with the development of atrial fibrillation after elective cardiac surgery

Speaker: Doctor N. Kazem (Vienna, AT)
Thumbnail

Asymmetric and symmetric dimethylarginine in atrial fibrillation progression and recurrence

Speaker: Doctor P. Buettner (Leipzig, DE)
Thumbnail

Ser96Ala genetic variant of human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation

Speaker: Doctor M. Amioka (Hiroshima, JP)
Thumbnail

Serum light-chain neurofilament is associated with brain atrophy in patients with atrial fibrillation

Speaker: Doctor S. Aeschbacher (Basel, CH)
Thumbnail

Predictors of left atrial thrombosis in patients undergoing planned electrical cardioversion of atrial fibrillation treated with direct anticoagulant

Speaker: Doctor V. Lio (Turin, IT)
Thumbnail

Single-procedure success-rate of pulmonary vein isolation using point-by-point tagging lesions algorithm based on contact force technology: preliminary results of the multicentric SMOP study

Speaker: Doctor S. Cornara (Savona, IT)
Thumbnail

Prescription of guideline recommended oral anticoagulation and reasons reported for non-use of OAC in patients with atrial fibrillation: Data from the German AFNET-2 Registry

Speaker: Professor M. Naebauer (Munich, DE)
Thumbnail

10 speakers from this session

Doctor Ekaterina Mironova

National Medical Research Center of cardiology, Moscow (Russian Federation)
0 follower

Doctor Tao Tu

The Second Xiangya Hospital of Central South University, Changsha (China)
0 follower

Professor Gary Tse

Tianjin Medical University, Tianjin (China)
0 follower

Doctor Niema Kazem

Medical University of Vienna, Vienna (Austria)
0 follower

Doctor Petra Buettner

Heart Center Leipzig at University of Leipzig, Leipzig (Germany)
0 follower

Doctor Michitaka Amioka

Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima (Japan)
0 follower

Doctor Stefanie Aeschbacher

University Hospital Basel, Basel (Switzerland)
0 follower

Doctor Veronica Lio

Maria Vittoria Hospital, Turin (Italy)
0 follower

Doctor Stefano Cornara

San Paolo Hospital, Savona (Italy)
0 follower

Professor Michael Naebauer

Ludwig-Maximilians University, Munich (Germany)
0 follower

This platform is supported by

logo Novo Nordisk